Comparison of camrelizumab, pembrolizumab, tislelizumab, and sintilimab as first-line treatment in patients with non-small cell lung cancer: a retrospective study
@article{JTD96416, author = {Xiaoqi Yan and Yizong Wang and Fei Wu and Guoren Zhou and Jiannan Shen and Shaorong Yu}, title = {Comparison of camrelizumab, pembrolizumab, tislelizumab, and sintilimab as first-line treatment in patients with non-small cell lung cancer: a retrospective study}, journal = {Journal of Thoracic Disease}, volume = {0}, number = {0}, year = {2025}, keywords = {}, abstract = {}, issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/96416} }